GRAZIANI, TIZIANO
 Distribuzione geografica
Continente #
NA - Nord America 1.037
EU - Europa 680
AS - Asia 472
AF - Africa 72
OC - Oceania 2
Totale 2.263
Nazione #
US - Stati Uniti d'America 1.028
GB - Regno Unito 202
VN - Vietnam 172
CN - Cina 135
SE - Svezia 111
IT - Italia 101
SG - Singapore 99
DE - Germania 80
IN - India 36
IE - Irlanda 33
TG - Togo 27
FR - Francia 24
CI - Costa d'Avorio 23
RU - Federazione Russa 22
CH - Svizzera 21
BG - Bulgaria 19
EE - Estonia 19
FI - Finlandia 19
JO - Giordania 19
ZA - Sudafrica 16
UA - Ucraina 10
CA - Canada 9
BE - Belgio 8
ES - Italia 8
NG - Nigeria 5
TH - Thailandia 3
IR - Iran 2
KZ - Kazakistan 2
AU - Australia 1
DK - Danimarca 1
ID - Indonesia 1
LB - Libano 1
LT - Lituania 1
NZ - Nuova Zelanda 1
PL - Polonia 1
SA - Arabia Saudita 1
SC - Seychelles 1
TW - Taiwan 1
Totale 2.263
Città #
Southend 187
Fairfield 148
Chandler 105
Singapore 84
Houston 68
Woodbridge 65
Seattle 64
Wilmington 64
Ashburn 62
Santa Clara 57
Cambridge 47
Princeton 38
Dublin 33
Bologna 32
Lomé 27
Abidjan 23
Dong Ket 23
Ann Arbor 20
Amman 19
Boardman 19
Helsinki 19
Sofia 19
Westminster 19
Beijing 18
Nanjing 17
Padova 17
Bern 15
Los Angeles 11
Jinan 10
Redwood City 10
Berlin 9
Turin 9
Brussels 8
New York 8
San Diego 8
Shenyang 8
Zhengzhou 8
Bremen 7
Changsha 7
Florence 7
Medford 6
Munich 6
Nanchang 6
Saint Petersburg 6
Toronto 6
Barcelona 5
Venezia 5
Abeokuta 4
Hebei 4
Shanghai 4
Jiaxing 3
Ottawa 3
Rome 3
Tianjin 3
Almería 2
Astana 2
Baoding 2
Dearborn 2
Falls Church 2
Hefei 2
Kuban 2
Lausanne 2
Leipzig 2
Milan 2
Norwalk 2
Olalla 2
Shenzhen 2
Shijiazhuang 2
Taiyuan 2
Wuxi 2
Abuja 1
Auckland 1
Bari 1
Brescia 1
Canberra 1
Cesena 1
Chicago 1
Clearwater 1
Costa Mesa 1
Dongguan 1
Foshan 1
Frankfurt am Main 1
Fuzhou 1
Fürstenwalde 1
Guangzhou 1
Haikou 1
Hangzhou 1
Hanover 1
Jakarta 1
Kaifeng 1
Kiev 1
Kumar 1
Lanzhou 1
Leawood 1
Linfen 1
London 1
Lucera 1
Magnago 1
Mountain View 1
Ningbo 1
Totale 1.545
Nome #
11C-Choline PET/CT in castration-resistant prostate cancer patients treated with docetaxel 173
68Ga-PSMA-11 PET/CT in recurrent prostate cancer: efficacy in different clinical stages of PSA failure after radical therapy. 161
11C-Choline PET/CT and Bladder Cancer: Lymph Node Metastasis Assessment With Pathological Specimens as Reference Standard 158
11C-Choline PET/CT Identifies Osteoblastic and Osteolytic Lesions in Patients with Metastatic Prostate Cancer. 142
Incidental detection of basaloid thymic carcinoma with 68 Ga-PSMA-11 PET/CT in recurrent prostate cancer patient 129
Liver metastases from prostate cancer at 11C-Choline PET/CT: a multicenter, retrospective analysis 123
Erratum to: Impact of 11C-choline PET/CT on clinical decision making in recurrent prostate cancer: results from a retrospective two-centre trial. 120
null 119
null 113
PET/CT and prostate cancer 111
PET imaging in prostate cancer, state of the art: a review of 18F-choline and 11C-choline PET/CT applications 103
PET/Computed Tomography in the Individualization of Treatment of Prostate Cancer. 99
The role of 18F-FDG PET/CT in the detection of osteosarcoma recurrence. 99
Response Evaluation to Radium-223-Dichloride in Castration-Resistant Metastatic Prostate Cancer using 11C-choline PET/CT and Bone Scintigraphy 95
Clinical impact of 11C-Choline PET/CT in recurrent prostate cancer patients after radical therapy: Which is the real impact on treatment decisions? 94
Role of 11C-Choline PET/CT in androgen sensitive prostate cancer patients treated with intermittent ADT: A sequential PET/CT study after therapy interruption 94
Detection of liver lesions during 11C-Choline PET/CT in relapsing prostate cancer patients 90
PET/CT in prostate cancer 86
Ga-68-PSMA PET/CT for early restaging prostate cancer. Preliminary results of a prospective trial in patients with biochemical failure after radical therapy and PSA levels< 2 ng/mL 82
11C-Choline PET/CT for restaging prostate cancer. Results from 4,426 scans in a single-centre patient series 72
68Ga-PSMA-11 PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy and PSA <0.5 ng/ml. Efficacy and impact on treatment strategy. 60
Totale 2.323
Categoria #
all - tutte 5.790
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.790


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020289 0 0 0 0 0 0 68 65 67 34 37 18
2020/2021246 51 16 8 2 4 17 6 19 31 6 12 74
2021/2022476 149 14 15 44 32 19 7 24 14 10 91 57
2022/2023476 33 60 20 72 28 31 13 27 108 19 36 29
2023/2024120 23 26 4 8 9 30 6 1 3 3 2 5
2024/2025289 30 53 31 49 86 36 4 0 0 0 0 0
Totale 2.323